Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 11, 2019

SELL
$178.4 - $208.25 $2.59 Million - $3.03 Million
-14,530 Closed
0 $0
Q3 2017

Oct 16, 2017

BUY
$167.29 - $191.0 $2.43 Million - $2.78 Million
14,530
14,530 $2.71 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Chickasaw Capital Management LLC Portfolio

Follow Chickasaw Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chickasaw Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chickasaw Capital Management LLC with notifications on news.